Grit Biotechnology (上海沙砾生物科技有限公司, also known as Shanghai Shashi Biotechnology) is a cell therapy company developing tumor-infiltrating lymphocyte (TIL) therapies for the treatment of solid tumors. It offers a technology platform for drug development and the preparation of medicines.